IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Dicle Tıp Dergisi
  • Volume:42 Issue:2
  • Adalimumab tedavisi alan romatoid artritli hastada seksüel disfonksiyon

Adalimumab tedavisi alan romatoid artritli hastada seksüel disfonksiyon

Authors : Levent YAZMALAR, Mustafa SARIYILDIZ, İbrahim BATMAZ
Pages : 0-0
Doi:10.5798/diclemedj.0921.2015.02.0570
View : 23 | Download : 7
Publication Date : 2015-07-08
Article Type : Other Papers
Abstract :Rheumatoid arthritis (RA) is a chronic, systemic and inflammatory disease characterized by symmetric polyarthritis and arthralgia, morning stiffness, fatigue and rheumatoid nodules. Multifactorial etiology such as genetic, infectious, hormonal or environmental factors contribute to disease susceptibility. However, clear etiology is not still defined. Both women and men with RA suffer from decreased sexual function. Also, many factors include disease activity, medications or psychological disorders can affect sexual health in a patients with RA. Sexual health is important for human life. However, often overlooked is the association between RA and sexual problems in clinical practice. We present a case of sexual dysfunction developing after adalimumab treatment in a man patient with RA. Key words: Rheumatoid arthritis, adalimumab, sexual dysfunction
Keywords : Romatoid artrit, adalimumab, seksüel disfonksiyon

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025